Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Neoantigen-driven cancer vaccines: Revolutionizing precision oncology through personalized immunotherapy

2025International Journal of Biological and Pharmaceutical Sciences ArchiveJournalOpen access

10.53771/ijbpsa.2025.10.1.0063 Full text1 citations

Authors

7 authors across 5 institutions in 2 countries.

Victor Chinedu NzereoguFirst authorCorresponding
- University of Nigeria (NG)
Christopher Chukwujindu Opoh
- University of Nigeria (NG)
Tobi John Oluwayemi
- University of Ibadan (NG)
Muhammad Ipoola Adeyemi
Mmesoma Vanessa Anakor
- University of Nigeria (NG)
Mercy Ebruvwiyo Umufo
- University of Benin (NG)
Safiyyah Temitope IsmaeelSenior author
- Usmanu Danfodiyo University (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Immunotherapy and Immune Responseslevel 3 · 1.00
vaccines and immunoinformatics approacheslevel 3 · 1.00
Monoclonal and Polyclonal Antibodies Researchlevel 3 · 1.00

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2025 · International Journal of Biological and Pharmaceutical Sciences Archive · 1 citations
https://openalex.org/W4413030069

Neoantigen-driven cancer vaccines: Revolutionizing precision oncology through personalized immunotherapy · Sankore